These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 36614096

  • 1. Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton's Jelly.
    Sypecka M, Bzinkowska A, Sulejczak D, Dabrowski F, Sarnowska A.
    Int J Mol Sci; 2022 Dec 30; 24(1):. PubMed ID: 36614096
    [Abstract] [Full Text] [Related]

  • 2. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC, Ferrari HF, Garcia AF, Novais JB, Silva-Frade C, Ferrarezi MC, Andrade AL, Gameiro R.
    BMC Biotechnol; 2012 May 04; 12():18. PubMed ID: 22559872
    [Abstract] [Full Text] [Related]

  • 3. A GMP-compliant manufacturing method for Wharton's jelly-derived mesenchymal stromal cells.
    Chu W, Zhang F, Zeng X, He F, Shang G, Guo T, Wang Q, Wu J, Li T, Zhong ZZ, Liang X, Hu J, Liu M.
    Stem Cell Res Ther; 2024 May 03; 15(1):131. PubMed ID: 38702793
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK, Pontikoglou C, Koutroulakis D, Pavlaki KI, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki HA.
    Stem Cell Res Ther; 2017 Apr 26; 8(1):102. PubMed ID: 28446235
    [Abstract] [Full Text] [Related]

  • 5. Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.
    Shi Q, Gao J, Jiang Y, Sun B, Lu W, Su M, Xu Y, Yang X, Zhang Y.
    Stem Cell Res Ther; 2017 Nov 02; 8(1):246. PubMed ID: 29096715
    [Abstract] [Full Text] [Related]

  • 6. DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.
    Shivakumar SB, Bharti D, Subbarao RB, Jang SJ, Park JS, Ullah I, Park JK, Byun JH, Park BW, Rho GJ.
    J Cell Biochem; 2016 Oct 02; 117(10):2397-412. PubMed ID: 27038129
    [Abstract] [Full Text] [Related]

  • 7. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H, Abediankenari S, Mohammadi M, Jafari N, Khalilian A, Rahmani Z, Momeninezhad Amiri M, Ebrahimi P.
    Acta Med Iran; 2018 Jan 02; 56(1):28-33. PubMed ID: 29436792
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
    Obradovic H, Krstic J, Trivanovic D, Mojsilovic S, Okic I, Kukolj T, Ilic V, Jaukovic A, Terzic M, Bugarski D.
    Placenta; 2019 Jul 02; 82():25-34. PubMed ID: 31174623
    [Abstract] [Full Text] [Related]

  • 10. Effect of Multiple Sclerosis Cerebrospinal Fluid and Oligodendroglia Cell Line Environment on Human Wharton's Jelly Mesenchymal Stem Cells Secretome.
    Salwierak-Głośna K, Piątek P, Domowicz M, Świderek-Matysiak M.
    Int J Mol Sci; 2022 Feb 16; 23(4):. PubMed ID: 35216294
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.
    Fong CY, Subramanian A, Biswas A, Bongso A.
    J Cell Biochem; 2016 Apr 16; 117(4):815-27. PubMed ID: 26365815
    [Abstract] [Full Text] [Related]

  • 13. Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration.
    Pu L, Meng M, Wu J, Zhang J, Hou Z, Gao H, Xu H, Liu B, Tang W, Jiang L, Li Y.
    Stem Cell Res Ther; 2017 Mar 21; 8(1):72. PubMed ID: 28320452
    [Abstract] [Full Text] [Related]

  • 14. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
    Liau LL, Ruszymah BHI, Ng MH, Law JX.
    Curr Res Transl Med; 2020 Jan 21; 68(1):5-16. PubMed ID: 31543433
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.
    Borys-Wójcik S, Brązert M, Jankowski M, Ożegowska K, Chermuła B, Piotrowska-Kempisty H, Bukowska D, Antosik P, Pawelczyk L, Nowicki M, Jeseta M, Kempisty B.
    J Biol Regul Homeost Agents; 2020 Jan 21; 33(1):119-123. PubMed ID: 30729769
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34+ cells.
    Zhao D, Liu L, Chen Q, Wang F, Li Q, Zeng Q, Huang J, Luo M, Li W, Zheng Y, Liu T.
    Stem Cell Res Ther; 2018 Jun 13; 9(1):158. PubMed ID: 29895317
    [Abstract] [Full Text] [Related]

  • 20. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
    Lee S, Park BJ, Kim JY, Jekarl D, Choi HY, Lee SY, Kim M, Kim Y, Park MS.
    Cytotherapy; 2015 Dec 13; 17(12):1723-31. PubMed ID: 26589753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.